Subcutaneous Administration of Superoxide Dismutase Entrapped in Long Circulating Liposomes: In Vivo Fate and Therapeutic Activity in an Inflammation Model

[1]  W. Oyen,et al.  Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. , 1999, Biochimica et biophysica acta.

[2]  G. Storm,et al.  Lymphatic Uptake and Biodistribution of Liposomes After Subcutaneous Injection: III. Influence of Surface Modification with Poly(ethyleneglycol) , 1997, Pharmaceutical Research.

[3]  D. Crommelin,et al.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. , 1997, Biochimica et biophysica acta.

[4]  W. Oyen,et al.  Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  J. Morais,et al.  Liposomal formulations of Cu,Zn-superoxide dismutase: physico-chemical characterization and activity assessment in an inflammation model , 1997 .

[6]  M. Hashida,et al.  Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism. , 1994, Biochemical pharmacology.

[7]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[8]  T. Allen,et al.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.

[9]  P. Strevens.  Iii , 1985, Middle Egyptian.

[10]  A. Baret,et al.  Pharmacokinetic and anti-inflammatory properties in the rat of superoxide dismutases (Cu SODs and Mn SOD) from various species. , 1984, Biochemical pharmacology.

[11]  I. Fridovich,et al.  Permeation of the erythrocyte stroma by superoxide radical. , 1978, The Journal of biological chemistry.

[12]  E. W. Kellogg,et al.  Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide. , 1977, The Journal of biological chemistry.

[13]  A. O. Allen,et al.  Mechanism of the disproportionation of superoxide radicals , 1977 .

[14]  R. Smith,et al.  Lowry determination of protein in the presence of Triton X-100. , 1975, Analytical biochemistry.

[15]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[16]  C. H. Fiske,et al.  THE COLORIMETRIC DETERMINATION OF PHOSPHORUS , 1925 .

[17]  M. Woodle,et al.  Long Circulating Liposome Therapeutics: From Concept to Clinical Reality , 1998 .

[18]  J. Hancock,et al.  Detection of superoxide and NADPH oxidase in porcine articular chondrocytes. , 1997, Free radical biology & medicine.

[19]  P. Vanelle,et al.  Clinical Pharmacokinetics and Delivery of Bovine Superoxide Dismutase , 1995, Clinical pharmacokinetics.

[20]  T. Allen,et al.  Subcutaneous administration of sterically stabilized (stealth) liposomes is an effective sustained release system for 1-β-d-arabinofuranosylcytosine , 1993 .

[21]  E. J. Dowling,et al.  Assessment of a human recombinant manganese superoxide dismutase in models of inflammation. , 1993, Free radical research communications.

[22]  M. Thakur.  Gallium-67 and indium-111 radiopharmaceuticals. , 1977, The International journal of applied radiation and isotopes.